By demonstrating that a human DCM-causing TTN mutation can be corrected to preserve cardiac function, our proof of concept study suggests exon skipping as a potential treatment approach for a substantial proportion of DCM patients. Here, TTN is linked to familial dilated cardiomyopathy.